Stay updated on Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial

Sign up to get notified when there's something new on the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating an increase in the number of participants enrolled in the study evaluating the reduction in cardiac amyloid load in patients with cardiac amyloidosis through repeated administrations of Anti-SAP treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:21:04.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age, gender, and health conditions required for inclusion. Previously, this section had no information provided.
    Difference
    60%
    Check dated 2024-05-22T20:31:04.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:14:12.000Z thumbnail image

Stay in the know with updates to Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page.